Ambrosia launches APIs for Abbott’s FreeStyle Libre and FreeStyle Libre Pro sensor data

To enable better diabetics management across hospitals and clinics around the world

San Francisco, California (Unites States)—October 23, 2018— Ambrosia Systems, a fast-growing medical technology company, today announced the launch of its APIs that allow healthcare providers access Abbott’s Freestyle and FreeStyle Libre Pro sensor data of diabetic patients in almost real-time, across hospitals and clinics around the world.

The APIs are relevant to all those consumers who are using Ambrosia’s LinkBluCon mobile app and NightRider Bluetooth sensor transmitter to monitor glucose levels on the go. The APIs work across phone manufacturers — Android and iOS platforms.

Ambrosia’s APIs help in better diabetics management as they integrate glucose readings of patients using Libre sensors along with other patient-related information like exercise regime, food and insulin intake and so on. The APIs also integrate patient history and records across hospitals and clinics wherever the patient has availed treatment. As a result,  healthcare providers get a holistic view of the patient’s condition with almost real-time glucose readings.

“Until now,  Abbott’s Libre sensor data was not accessible to healthcare providers around the world. Our APIs now make it possible for healthcare providers to access glucose readings of diabetics in almost real time,” said Piyush Gupta, CEO,  Ambrosia Systems.

Disclaimer:

Ambrosia apps are not FDA approved and should not be used to make medical decisions.

FreeStyle Libre is a trademark of Abbott Diabetes Care Inc. Ambrosia Systems Inc. does not have any partnership agreement or any kind of relationship with Abbott Diabetic Care or Abbott Laboratories.

Ambrosia Systems, 2018

About Ambrosia Systems

Ambrosia Systems is a fast-growing medical technology company focused on building easy to use and affordable technology solutions for patients and caregivers around the world. Our products and apps work with Abbott’s NFC-based FreeStyle Libre sensor to help patients continuously monitor their glucose levels on their mobile phone. This helps in better treatment and patient care leading to a healthier lifestyle and better quality of life for diabetics. Our low-cost Bluetooth sensor transmitter, NightRider BluCon, is currently in use in more than 100 countries. Our products work equally well over iPhone, Android phones, iPod and Apple/Android watch. To learn more, visit www.ambrosiasys.com or follow us @Ambrosia_Sys.

Media Contacts:

United States
Mia Flaherty
Ambrosia Systems
Phone:+1-415-293-8242
Email: mia.flaherty@ambrosiasys.com

Disclaimer: Freestyle libre Sensor is a trademark of Abbott Diabetes Care Inc.
Ambrosia Systems Inc. does not have any Partnership Agreement or any kind of relationship with Abbott Diabetic Care or Abbott Laboratories.
Ambrosia apps and device are not FDA approved. Hence, do not use the glucose readings to take any medical decisions.

0
    0
    Your Cart
    Your cart is emptyReturn to Shop